NORTHERN TRUST CORP - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 31 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$51,000
-33.8%
99,691
+20.7%
0.00%
Q4 2018$77,000
-47.6%
82,6050.0%0.00%
Q3 2018$147,000
+26.7%
82,6050.0%0.00%
Q2 2018$116,000
-0.9%
82,605
+7.0%
0.00%
Q1 2018$117,000
+20.6%
77,213
+61.3%
0.00%
Q4 2017$97,000
-16.4%
47,8590.0%0.00%
Q3 2017$116,000
-15.3%
47,8590.0%0.00%
Q2 2017$137,00047,8590.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,547,837$1,439,0003.20%
Anson Funds Management LP 607,113$565,0000.33%
Benin Management CORP 14,300$13,0000.01%
NORTHWEST WEALTH MANAGEMENT, LLC 4,000$4,0000.00%
WEDBUSH SECURITIES INC 25,500$24,0000.00%
Virtu Financial LLC 45,555$42,0000.00%
Northeast Financial Consultants Inc 15,000$14,0000.00%
Capital Advisory Group Advisory Services, LLC 900$1,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 103,100$96,0000.00%
FRONTIER INVESTMENT MGMT CO 20,000$19,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders